ME Therapeutics Holdings Inc. Share Price
Stocks
METX
CA5527671054
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Canadian Securities Exchange
14:45:22 17/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 1.750 CAD | -30.00% |
|
-30.00% | -56.25% |
| 07-17 | ME Therapeutics Holdings Inc. announced that it has received CAD 0.576501 million in funding | CI |
| 07-17 | ME Therapeutics Raises C$0.58 Million Via Non-Brokered Private Placement | MT |
| Market Cap | 51.66M 37.24M 32.15M 30.16M 27.47M 3.56B 52.38M 354M 139M 1.78B 140M 137M 5.93B | P/E 2024 |
-51.7x | P/E 2025 | -93.2x |
|---|---|---|---|---|---|
| Enterprise Value | 50.33M 36.28M 31.32M 29.39M 26.77M 3.47B 51.03M 344M 135M 1.74B 136M 133M 5.78B | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
44.63% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -30.00% | ||
| 1 week | -30.00% | ||
| Current month | -30.00% | ||
| 1 month | -40.48% | ||
| 3 months | -40.68% | ||
| 6 months | -41.47% | ||
| Current year | -56.25% |
| 1 week | 1.7 |  | 1.8 |
| 1 month | 1.7 | | 3.04 |
| Current year | 0.79 | | 3.8 |
| 1 year | 0.79 | | 8 |
| 3 years | 0.05 | | 11 |
| 5 years | 0.05 | | 11 |
| 10 years | 0.05 | | 11 |
| Manager | Title | Age | Since |
|---|---|---|---|
Salim Dhanji
CEO | Chief Executive Officer | 46 | 08/03/2023 |
Quinn Martin
DFI | Director of Finance/CFO | 44 | 08/03/2023 |
Karim Lalji
PRN | Corporate Officer/Principal | - | 24/10/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
John Priatel
BRD | Director/Board Member | 60 | 08/03/2023 |
Salim Dhanji
BRD | Director/Board Member | 46 | 08/03/2023 |
Kenneth Harder
BRD | Director/Board Member | 59 | 08/03/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 16/07/26 | Option | Director | 294,118 | 0.9788% | ||
| 16/07/26 | Sell | Director | 294,118 | 0.9788% | ||
| 16/07/26 | Option | Chief Financial Officer | 125,000 | 0.4160% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -30.00% | -30.00% | -56.25% | - | 54.75M | |
| +0.68% | -2.28% | +2.16% | +19.70% | 48.42B | |
| +4.07% | +2.43% | +483.70% | +623.80% | 43.66B | |
| +4.33% | +0.98% | +12.80% | +88.53% | 39.51B | |
| +1.94% | -0.31% | +26.24% | +12.62% | 38.95B | |
| -0.50% | 0.00% | +20.60% | +60.49% | 32.61B | |
| -0.44% | -3.22% | - | - | 16.32B | |
| +3.22% | -0.88% | +30.42% | +135.47% | 16.15B | |
| -0.62% | -0.06% | +3.46% | +27.74% | 14.16B | |
| +2.35% | +3.48% | +82.95% | +43.41% | 13.37B | |
| Average | -1.50% | +0.02% | +67.34% | +126.47% | 26.32B | |
| Weighted average by Cap. | +1.93% | +0.04% | +101.55% | +151.17% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -1.29M -933K -806K -756K -689K -89.24M -1.31M -8.86M -3.47M -44.71M -3.5M -3.43M -149M | -1.19M -860K -743K -697K -635K -82.25M -1.21M -8.17M -3.2M -41.21M -3.23M -3.16M -137M |
| Net Debt | -1.5M -1.08M -932K -874K -796K -103M -1.52M -10.24M -4.01M -51.69M -4.05M -3.96M -172M | -1.33M -960K -829K -777K -708K -91.76M -1.35M -9.11M -3.57M -45.97M -3.6M -3.53M -153M |
Employees
-
| Date | Price | Change | Volume |
|---|
- Stock Market
- Stocks
- METX Stock
Select your edition
All financial news and data tailored to specific country editions
